Skip to main content
SpringerLink
Log in

Hybrid imaging of the abdomen and pelvis

Hybridbildgebung bei abdominellen Erkrankungen. Englische Version

  • Leitthema
  • Published:
Der Radiologe Aims and scope Submit manuscript

Abstract

Accurate imaging is crucial for lesion detection in abdominal organs, for the noninvasive characterization of focal and diffuse abnormalities, and for surgical planning. To accomplish these tasks, several imaging modalities such as multidetector computer tomography (MDCT), magnetic resonance imaging (MRI) and positron emission tomography/computed tomography (PET/CT) are used for abdominal imaging, providing important morphological, functional or metabolic information. More recently, PET/MRI has been gaining attention due to the possibility of combining high-resolution imaging with metabolic imaging. PET/MRI is a novel hybrid imaging technology that in the near future might play a pivotal role in the clinical management of oncologic and inflammatory abdominopelvic diseases. Despite the still limited number of published clinical studies, PET/MRI has been proven to be at least equivalent to PET/CT and to standalone MRI in a variety of oncologic disease. Moreover, in selected and focused clinical studies, it has been proven to outperform current standard of care imaging, for example, in evaluating cholangiocarcinomas, liver metastases, untreated and treated rectal cancer. This has also had an impact on therapeuticmanagement in some studies. Therefore in some institutions, including those of the authors, PET/MRI is becoming the new standard imaging modality in staging treatment-naïve intrahepatic massforming cholangiocarcinomas and prior to complicated hepatic surgery.

Zusammenfassung

Eine adäquate Bildgebung ist für die Detektion mitunter kleinster Läsionen, die noninvasive Charakterisierung von fokalen und diffusen Veränderungen, sowie die Planung chirurgischer Eingriffe von entscheidender Bedeutung. Zur Bewältigung dieser Aufgaben werden verschiedene bildgebende Verfahren wie die Multidetektor-Computertomographie (MDCT), Magnetresonanztomographie (MRT) und Positronen-Emissions-Tomographie/Computertomographie (PET/CT) eingesetzt, die wichtige morphologische, funktionelle oder metabolische Informationen liefern. In letzter Zeit gewinnt die PET/MRT aufgrund der Möglichkeit von Kombination hochauflösender Bildgebung und metabolischer Bildgebung zunehmend an Aufmerksamkeit. Die PET/MRT ist eine neuartige Hybridbildgebungstechnologie, die in naher Zukunft eine zentrale Rolle bei der klinischen Behandlung von onkologischen und entzündlichen Abdomen-Becken-Erkrankungen spielen könnte. Trotz der noch begrenzten Anzahl publizierter klinischer Studien hat sich die PET/MRT bei einer Vielzahl von onkologischen Erkrankungen als zumindest gleichwertig wie PET/CT und MRT als Einzeluntersuchung erwiesen. In ausgewählten und fokussierten klinischen Studien wurde zudem nachgewiesen, dass es die derzeitige Standardbildgebung beispielsweise in der Beurteilung von Cholangiokarzinomen, Lebermetastasen sowie unbehandelten und behandelten Rektumkarzinomen übertrifft. Dies hat sich in einigen Studien auch auf das therapeutische Management ausgewirkt. Daher ist die PET/MRT in einigen Institutionen zur neue Standardbildgebungsmethode, z. B. bei unbehandelten intrahepatischen Cholangiokarzinomen sowie vor komplizierten Leberoperationen geworden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Aklilu M, Eng C (2011) The current landscape of locally advanced rectal cancer. Nat Rev Clin Oncol 8(11):649–659

    Article  PubMed  CAS  Google Scholar 

  2. Amorim BJ, Theodore SH, Blaszkowsky LS, Ferrone CR, Berger DL, Bordeianou LG, Ricciardi R et al (2019) Clinical impact of PET/MR in treated colorectal cancer patients. Eur J Nucl Med Mol Imaging 46(11):2260–2269

    Article  PubMed  Google Scholar 

  3. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, Bockisch A, Debatin JF, Freudenberg LS (2003) Non–small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229(2):526–533

    Article  PubMed  Google Scholar 

  4. Atkinson W, Catana C, Abramson JS, Arabasz G, McDermott S, Catalano O, Muse V et al (2016) Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients. Abdom Radiol 41(7):1338–1348

    Article  Google Scholar 

  5. Beiderwellen K, Llanos G, Ruhlmann V, Heusch P, Gomez B, Nensa F, Umutlu L, Lauenstein TC (2015) Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases. PLoS ONE. https://doi.org/10.1371/journal.pone.0137285

    Article  PubMed  PubMed Central  Google Scholar 

  6. Brendle C, Schwenzer NF, Rempp H, Schmidt H, Pfannenberg C, la Fougère C, Nikolaou K, Schraml C (2016) Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-015-3137-z

    Article  PubMed  Google Scholar 

  7. Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, Geraint TW (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227(2):371–377

    Article  PubMed  Google Scholar 

  8. Catalano OA, Coutinho AM, Sahani DV, Vangel MG, Gee MS, Hahn PF, Witzel T et al (2017) Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR. Abdom Radiol 42(4):1141–1151

    Article  Google Scholar 

  9. Catalano OA, Gee MS, Emanuele N, Selvaggi F, Pellino G, Cuocolo A, Luongo A et al (2016) Evaluation of quantitative PET/MR enterography biomarkers for discrimination of inflammatory strictures from fibrotic strictures in Crohn disease. Radiology 278(3):792–800

    Article  PubMed  Google Scholar 

  10. Catalano OA, Wu V, Mahmood U, Signore A, Vangel M, Soricelli A, Salvatore M, Gervais D, Rosen BR (2018) Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn disease. Am J Nuclear Med Mol Imaging 8(1):62–69

    CAS  Google Scholar 

  11. Catalano OA, Rosen BR, Sahani DV, Hahn PF, Guimaraes AR, Vangel MG, Nicolai E, Soricelli A, Salvatore M (2013) Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients—a hypothesis-generating exploratory study. Radiology. https://doi.org/10.1148/radiology.13131306

    Article  PubMed  Google Scholar 

  12. Catalano O, Kilcoyne A, Signore A, Mahmood U, Rosen B (2018) Lower gastrointestinal tract applications of PET/computed tomography and PET/MR imaging. Radiol Clin North Am 56(5):821–834

    Article  PubMed  Google Scholar 

  13. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1261–1268

    Article  PubMed  Google Scholar 

  14. Chen B‑B, Tien Y‑W, Chang M‑C, Cheng M‑F, Chang Y‑T, Wu C‑H, Chen X‑J et al (2016) PET/MRI in pancreatic and Periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-016-3356-y

    Article  PubMed  PubMed Central  Google Scholar 

  15. Choi M, Kollepara SLS, Heilbrun LK, Smith D, Shields AF, Philip PA (2015) PET scans as a predictive marker of survival in advanced colorectal cancer. Clin Colorectal Cancer 14(1):35–40

    Article  PubMed  Google Scholar 

  16. Delso G, Fürst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, Schwaiger M, Ziegler SI (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52(12):1914–1922

    Article  PubMed  Google Scholar 

  17. Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D (2010) Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med. https://doi.org/10.2967/jnumed.109.068510

    Article  PubMed  Google Scholar 

  18. Einspieler I, Thürmel K, Pyka T, Eiber M, Wolfram S, Moog P, Reeps C, Essler M (2015) Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-015-3007-8

    Article  PubMed  Google Scholar 

  19. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247

    Article  CAS  PubMed  Google Scholar 

  20. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144(8):1941–1953

    Article  PubMed  CAS  Google Scholar 

  21. Ferrone C, Goyal L, Qadan M, Gervais D, Sahani DV, Zhu AX, Hong TS et al (2019) Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated Intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-019-04558-3

    Article  PubMed  Google Scholar 

  22. Fraum TJ, Fowler KJ, McConathy J, Dehdashti F (2016) Indeterminate findings on oncologic PET/CT: what difference does PET/MRI make? Nucl Med Mol Imaging. https://doi.org/10.1007/s13139-016-0405-1

    Article  PubMed  PubMed Central  Google Scholar 

  23. de Geus-Oei L‑F, Vriens D, van Laarhoven HWM, van der Graaf WTA, Oyen WJG (2009) Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review. J Nucl Med 43S–54S. https://doi.org/10.2967/jnumed.108.057224

  24. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R et al (2004) Cytoreductive surgery combined with perioperative Intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. https://doi.org/10.1200/jco.2004.10.012

    Article  PubMed  Google Scholar 

  25. Heacock L, Weissbrot J, Raad R, Campbell N, Friedman KP, Ponzo F, Chandarana H (2015) PET/MRI for the evaluation of patients with lymphoma: initial observations. AJR Am J Roentgenol 204(4):842–848

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hectors SJ, Wagner M, Besa C, Huang W, Taouli B (2018) Multiparametric FDG-PET/MRI of hepatocellular carcinoma: initial experience. Contrast Media Mol Imaging. https://doi.org/10.1155/2018/5638283

    Article  PubMed  PubMed Central  Google Scholar 

  27. Horvat N, Petkovska I, Gollub MJ (2018) MR imaging of rectal cancer. Radiol Clin North Am 56(5):751–774

    Article  PubMed  Google Scholar 

  28. Hu J, Chen F‑Y, Zhou K‑Q, Zhou C, Cao Ya, Hui-Chuan S, Fan J, Zhou J, Wang Z (2017) Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection. Oncotarget 8(69):113817–113827

    Article  PubMed  PubMed Central  Google Scholar 

  29. Jerusalem G, Beguin Y, Najjar F, Hustinx R, Fassotte MF, Rigo P, Fillet G (2001) Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade Non-Hodgkin’s Lymphoma (NHL). Ann Oncol 12(6):825–830

    Article  PubMed  CAS  Google Scholar 

  30. Joo I, Lee JM, Lee DH, Lee ES, Paeng JC, Lee JC, Jang J‑Y, Kim S‑W, Ryu JK, Lee K‑B (2017) Preoperative assessment of pancreatic cancer with FDG PET/MR imaging versus FDG PET/CT plus contrast-enhanced multidetector CT: a prospective preliminary study. Radiology. https://doi.org/10.1148/radiol.2016152798

    Article  PubMed  Google Scholar 

  31. Kang B, Jeong ML, Sub YS, Woo S, Hur BY, Jeon JH, Paeng JC (2016) Added value of integrated whole-body PET/MRI for evaluation of colorectal cancer: comparison with contrast-enhanced MDCT. Am J Roentgenol 206(1):W10–W20

    Article  Google Scholar 

  32. Kawaoka T, Aikata H, Takaki S, Uka K, Azakami T, Saneto H, Jeong SC et al (2009) FDG positron emission tomography/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma. Hepatol Res 39(2):134–142

    Article  PubMed  Google Scholar 

  33. Kayani I, Bomanji JB, Groves A, Conway G, Gacinovic S, Win T, Dickson J, Caplin M, Ell PJ (2008) Functional imaging of neuroendocrine tumors with combined PET/CT using 68ga-DOTATATE (DOTA-DPhe1, Tyr3-Octreotate) and 18F-FDG. Cancer 112(11):2447–2455

    Article  PubMed  Google Scholar 

  34. Kelly H, Goldberg RM (2005) Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol 23(20):4553–4560

    Article  PubMed  CAS  Google Scholar 

  35. van Kessel CS, Buckens CFM, van den Bosch MAAJ, van Leeuwen MS, van Hillegersberg R, Verkooijen HMV (2012) Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol 19(9):2805–2813

    Article  PubMed  PubMed Central  Google Scholar 

  36. Kim JY, Myung-Hwan K, Tae YL, Hwang CY, Kim JS, Yun S‑C, Lee SS, Seo DW, Lee SK (2008) Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterology 103(5):1145–1151

    Article  Google Scholar 

  37. Kirchner J, Kirchner EM, Goltz JP, Lorenz V‑W, Kickuth R (2011) Prevalence of enlarged mediastinal lymph nodes in heavy smokers—a comparative study. Eur Radiol 21(8):1594–1599

    Article  PubMed  Google Scholar 

  38. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348(25):2500–2507

    Article  PubMed  Google Scholar 

  39. Lee DH, Lee JM, Hur BY, Joo I, Yi N‑J, Suh K‑S, Kang KW, Han JK (2016) Colorectal cancer liver metastases: diagnostic performance and prognostic value of PET/MR imaging. Radiology 280(3):782–792

    Article  PubMed  Google Scholar 

  40. Leonard GD, Brenner B, Kemeny NE (2005) Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23(9):2038–2048

    Article  PubMed  CAS  Google Scholar 

  41. Li Y, Langhorst J, Koch AK, Demircioglu A, Nensa F, Kirchner J, Beiderwellen K et al (2019) Assessment of Ileocolonic inflammation in Crohn’s disease: which surrogate marker is better-maRIA, Clermont, or PET/MR index? Initial results of a feasibility trial. J Nucl Med 60(6):851–857

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Lötsch F, Waneck F, Auer H, Kaczirek K, Karanikas G, Ramharter M (2017) FDG-PET/MRI in alveolar Echinococcosis. Int J Infect Dis. https://doi.org/10.1016/j.ijid.2017.09.006

    Article  PubMed  Google Scholar 

  43. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier A‑M (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244(2):254–259

    Article  PubMed  PubMed Central  Google Scholar 

  44. Mayerhoefer ME, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, Berzaczy D et al (2019) PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-019-04452-y

    Article  PubMed  PubMed Central  Google Scholar 

  45. Milojevic ITG, Milojevic B, Sobic-Saranovic DP, Artiko VM (2018) Impact of hybrid molecular imaging in Retroperitoneal fibrosis: a systematic review. Rheumatol Int. https://doi.org/10.1007/s00296-017-3798-y

    Article  PubMed  Google Scholar 

  46. Misra DP, Wakhlu A, Agarwal V, Danda D (2019) Recent advances in the management of takayasu arteritis. Int J Rheum Dis 22(Suppl 1):60–68

    Article  PubMed  CAS  Google Scholar 

  47. Mueller-Lisse UG, Mueller-Lisse UL, Meindl T, Coppenrath E, Degenhart C, Graser A, Scherr M, Reiser MF (2007) Staging of renal cell carcinoma. Eur Radiol 17(9):2268–2277

    Article  PubMed  Google Scholar 

  48. Nasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S, Motoori K, Ueda T (2006) Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 239(1):122–130

    Article  PubMed  Google Scholar 

  49. Ozawa Y, Hara M, Sakurai K, Nakagawa M, Tamaki T, Nishio M, Shibamoto Y (2010) Diagnostic accuracy of 18F-2-Deoxy-Fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Acta Radiol 51(2):150–155

    Article  PubMed  Google Scholar 

  50. Pace L, Emanuele N, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M (2014) Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-Deoxyglucose uptake in lesions and in normal organ tissues. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2013.11.002

    Article  PubMed  Google Scholar 

  51. Padhani AR, Koh D‑M, Collins DJ (2011) Whole-body diffusion-weighted MR imaging in cancer: current status and research direction. Radiology 261(3):700–718

    Article  PubMed  Google Scholar 

  52. Park J‑W, Kim JH, Kim SK, Kang KW, Park KW, Choi J‑I, Lee WJ, Kim C‑M, Nam BH (2008) A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma. J Nucl Med 49(12):1912–1921

    Article  PubMed  Google Scholar 

  53. Pellino G, Nicolai E, Catalano OA, Campione S, D’Armiento FP, Salvatore M, Cuocolo A, Selvaggi F (2016) PET/MR versus PET/CT imaging: impact on the clinical management of small-bowel Crohn’s disease. J Crohns Colitis 10(3):277–285

    Article  PubMed  Google Scholar 

  54. Plodeck V, Rahbari NN, Weitz J, Radosa CG, Laniado M, Hoffmann R‑T, Zöphel K et al (2019) FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences. Eur Radiol 29(1):422–428

    Article  PubMed  Google Scholar 

  55. Ponisio MR, McConathy J, Laforest R, Khanna G (2016) Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Pediatr Radiol 46(9):1258–1268

    Article  PubMed  PubMed Central  Google Scholar 

  56. Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma—evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15(2):95–111

    Article  PubMed  CAS  Google Scholar 

  57. Ruhlmann V, Poeppel TD, Brandt AS, Grueneisen J, Ruhlmann M, Theysohn JM, Forsting M, Bockisch A, Umutlu L (2016) Erratum to: 18F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-016-3376-7

    Article  PubMed  Google Scholar 

  58. Ryan DP, Theodore SH, Bardeesy N (2014) Pancreatic adenocarcinoma. N Engl J Med 371:1039–1049. https://doi.org/10.1056/NEJMra1404198

  59. Sailer AM, Bakers FC, Daemen JW, Vöö S (2018) 18F-FDG PET/MRI in the diagnosis of an infected aortic aneurysm. Cardiovasc Diagn Ther. https://doi.org/10.21037/cdt.2017.08.05

    Article  PubMed  PubMed Central  Google Scholar 

  60. von Schulthess GK, Schlemmer H‑PW (2009) A look ahead: PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging 36(1):3–9

    Article  Google Scholar 

  61. Sharma P, Kumar R, Singh H, Jeph S, Sharma DN, Bal C, Malhotra A (2012) Carcinoma endometrium: role of 18-FDG PET/CT for detection of suspected recurrence. Clin Nucl Med 37(7):649–655

    Article  PubMed  Google Scholar 

  62. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30

    Article  PubMed  Google Scholar 

  63. Slart RHJA1, Writing group, Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, Members of Committees et al (2018) FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET interest group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-018-3973-8

    Article  Google Scholar 

  64. Son H, Khan SM, Rahaman J, Cameron KL, Prasad-Hayes M, Chuang L, Machac J, Heiba S, Kostakoglu L (2011) Role of FDG PET/CT in staging of recurrent ovarian cancer. Radiographics 31(2):569–583

    Article  PubMed  Google Scholar 

  65. Thuermel K, Einspieler I, Wolfram S, Moog P, Meier R, Schwaiger M, Heemann U (2017) Disease Activity and Vascular Involvement in Retroperitoneal Fibrosis: First Experience with Fully Integrated 18F-Fluorodeoxyglucose Positron Emission Tomography/magnetic Resonance Imaging Compared to Clinical and Laboratory Parameters. Clin Exp Rheumatol 35(Suppl 103 (1)):146–154

    PubMed  Google Scholar 

  66. Torigian DA, Zaidi H, Kwee TC, Saboury B, Udupa JK, Cho Z‑H, Alavi A (2013) PET/MR imaging: technical aspects and potential clinical applications. Radiology 267(1):26–44

    Article  PubMed  Google Scholar 

  67. Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J (1995) In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 36(10):1811–1817

    PubMed  CAS  Google Scholar 

  68. Tsikitis VL, Larson DW, Huebner M, Lohse CM, Thompson PA (2014) Predictors of recurrence free survival for patients with stage II and III colon cancer. BMC Cancer 14:336

    Article  PubMed  PubMed Central  Google Scholar 

  69. Vaglio A, Salvarani C, Buzio C (2006) Retroperitoneal fibrosis. Lancet. https://doi.org/10.1016/s0140-6736(06)68035-5

    Article  PubMed  Google Scholar 

  70. Venook AP, Papandreou C, Furuse J, Ladrón de Guevara L (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. The Oncol 15(Suppl 4):5–13

    Article  Google Scholar 

  71. Wenter V, Sommer NN, Kooijman H, Maurus S, Treitl M, Czihal M, Dechant C, Unterrainer M, Albert NL, Treitl KM (2018) Clinical value of [18F] FDG-PET/CT and 3D-black-blood 3T-MRI for the diagnosis of large vessel vasculitis and single-organ vasculitis of the aorta. Q J Nucl Med Mol Imaging. https://doi.org/10.23736/S1824-4785.18.03036-4

  72. Wilhelmsen M, Kring T, Jorgensen LN, Rørbæk Madsen M, Jess P, Bulut O, Nielsen KT, Lindbjerg Andersen C, Nielsen HJ (2014) Determinants of recurrence after intended curative resection for colorectal cancer. Scand J Gastroenterol 49(12):1399–1408

    Article  PubMed  Google Scholar 

  73. Wudel LJ Jr, Delbeke D, Morris D, Rice M et al (2003) The role of [\^ sup 18\^ F] fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma/discussion. Am Surg 69(2):117

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Abdominal Radiology, Massachusetts General Hospital, Boston, MA, USA

    Krista Elise Suarez-Weiss, Debra Gervais, Edwin Palmer, Joseph D. King, Li Weier, Tajmir Shahein & Onofrio A. Catalano MD, PhD

  2. University of Vienna, Vienna, Austria

    Alexander Herold

  3. Campinas State University, Campinas, Brazil

    Bárbara Amorim

  4. Tel Aviv University, Tel Aviv, Israel

    Hanna Bernstine, Liran Domachevsk & David Groshar

  5. HM Hospitales, Madrid, Spain

    Lina Garcia Cañamaque

  6. University of Naples Parthenope, Naples, Italy

    Onofrio A. Catalano MD, PhD

  7. Harvard Medical School, Massachusetts General Hospital, 55 Fruits St, Boston, MA, USA

    Onofrio A. Catalano MD, PhD

Authors
  1. Krista Elise Suarez-Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander Herold
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Debra Gervais
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Edwin Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bárbara Amorim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joseph D. King
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Li Weier
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tajmir Shahein
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hanna Bernstine
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Liran Domachevsk
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Lina Garcia Cañamaque
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ken Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Lale Umutlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. David Groshar
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Onofrio A. Catalano MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Onofrio A. Catalano MD, PhD.

Ethics declarations

Conflict of interest

K.E. Suarez-Weiss, A. Herold, D. Gervais, E. Palmer, B. Amorim, J.D. King, L. Weier, T. Shahein, H. Bernstine, L. Domachevsk, L.G. Cañamaque, K. Herrmann, L. Umutlu, D. Groshar and O.A. Catalano declare that they have no competing interests.

For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case. The patients whose images have been used in this review paper are part of other IRB aproved research studies.

The supplement containing this article is not sponsored by industry.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suarez-Weiss, K.E., Herold, A., Gervais, D. et al. Hybrid imaging of the abdomen and pelvis. Radiologe 60 (Suppl 1), 80–89 (2020). https://doi.org/10.1007/s00117-020-00661-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00117-020-00661-x

Keywords

Schlüsselwörter

Search

Navigation